nad has been researched along with Dementia Praecox in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (70.59) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cohen, BM; Du, F; Kim, SY; Li, T; Lukas, SE; Öngür, D; Shinn, AK; Yuksel, AC | 1 |
| Chouinard, G; Chouinard, VA; Cohen, BM; Du, F; Kim, SY; Öngür, D; Ryan, KP; Valeri, L; Yuksel, C | 1 |
| Penberthy, WT | 1 |
| Miller, CL | 1 |
| Curti, D; Das Gupta, F; Ferrier, IN; Jones, S; Marchbanks, RM; Taylor, C; Whatley, SA | 1 |
| Ban, TA | 2 |
| Barclay, GL; Cole, JO; Esser, AH; Kline, NS; Lehmann, HE; Wittenborn, JR | 1 |
| Bishop, MP; Gallant, DM; Steele, CA | 1 |
| Barclay, GL; Cole, JO; Esser, AH; Kline, NS; Lehmann, H; Wittenborn, JR | 1 |
| Hoffer, A; Osmond, H | 1 |
| Grinspoon, L; Meltzer, H; Shader, R | 1 |
| Gershon, S; Shopsin, B | 1 |
| Hansen, O | 1 |
| Mamtsev, VP | 1 |
| Altus, MS | 1 |
1 review(s) available for nad and Dementia Praecox
| Article | Year |
|---|---|
Alcoholism and schizophrenia: diagnostic and therapeutic considerations.
Topics: Alcoholism; Brain; Disulfiram; Dopamine; Humans; Methyltyrosines; Metronidazole; NAD; Norepinephrine; Schizophrenia; Tyrosine | 1977 |
6 trial(s) available for nad and Dementia Praecox
| Article | Year |
|---|---|
Nicotinic acid in the treatment of schizophrenias. Practical and theoretical considerations.
Topics: Adrenochrome; Antipsychotic Agents; Ascorbic Acid; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Humans; NAD; Nicotinic Acids; Pellagra; Phenothiazines; Pyridoxine; Schizophrenia | 1975 |
Diphosphopyridine nucleotide in the treatment of schizophrenia.
Topics: Adult; Humans; Middle Aged; NAD; Placebos; Schizophrenia; Tablets, Enteric-Coated | 1967 |
Controlled evaluation of nicotinamide adenine dinucleotide in the treatment of chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Hallucinations; Humans; Interview, Psychological; Male; Middle Aged; NAD; Placebos; Projective Techniques; Psychological Tests; Schizophrenia | 1967 |
Nicotinamide adenine dinucleotide in the treatment of chronic schizophrenic patients.
Topics: Chronic Disease; Clinical Trials as Topic; Humans; NAD; Schizophrenia | 1968 |
The behavioral effects of nicotinamide adenine dinucleotide in chronic schizophrenia.
Topics: Adult; Clinical Trials as Topic; Drug Synergism; Humans; Male; NAD; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Tablets, Enteric-Coated; Thioridazine | 1969 |
Plasma cortisol response to dexamethasone suppression in depressed and control patients.
Topics: Adjustment Disorders; Adult; Amines; Chlorpromazine; Circadian Rhythm; Depression; Depression, Chemical; Dexamethasone; Diet; Female; Humans; Hydrocortisone; Imipramine; Lithium; Male; Middle Aged; NAD; Naphthalenes; Placebos; Schizophrenia | 1971 |
10 other study(ies) available for nad and Dementia Praecox
| Article | Year |
|---|---|
Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.
Topics: Adult; Bipolar Disorder; Humans; Magnetic Resonance Spectroscopy; NAD; Oxidation-Reduction; Oxidative Stress; Schizophrenia | 2017 |
Brain bioenergetics and redox state measured by
Topics: Adolescent; Adult; Bipolar Disorder; Female; Frontal Lobe; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; NAD; Oxidation-Reduction; Phosphorus Isotopes; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Siblings; Young Adult | 2017 |
Nicotinamide adenine dinucleotide biology and disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Multiple Sclerosis; NAD; Neoplasms; Schizophrenia; Tuberculosis | 2009 |
The evolution of schizophrenia: a model for selection by infection, with a focus on NAD.
Topics: Biological Evolution; Humans; Kynurenine; Models, Biological; NAD; Schizophrenia; Selection, Genetic; Tuberculosis | 2009 |
Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Brain Chemistry; Cytochrome Reductases; Cytochrome-B(5) Reductase; Female; Flupenthixol; Gene Expression Regulation, Enzymologic; Humans; In Situ Hybridization; Lipid Peroxidation; Lymphocytes; Male; Middle Aged; Mitochondria; NAD; NAD(P)H Dehydrogenase (Quinone); Oligonucleotide Probes; Oxidative Stress; RNA, Messenger; Schizophrenia; Superoxides; Ubiquinone | 1998 |
DPN (NAD-oxidized form): a preliminary evaluation in chronic schizophrenic patients.
Topics: Adult; Humans; NAD; Schizophrenia | 1966 |
Blood nucleoside and nucleotide studies in mental disease.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adjustment Disorders; Adult; Bipolar Disorder; Chromatography, Thin Layer; Cyclic AMP; Erythrocytes; Female; Humans; Hydrolysis; Male; Mental Disorders; Middle Aged; NAD; Neurotic Disorders; Schizophrenia; Uridine Diphosphate Sugars | 1972 |
[Oxidative enzyme activity in the peripheral blood leukocytes of patients with nuclear schizophrenia].
Topics: Acute Disease; Adolescent; Adult; Chronic Disease; Dihydrolipoamide Dehydrogenase; Electron Transport Complex IV; Humans; Leukocytes; NAD; Schizophrenia; Succinate Dehydrogenase | 1973 |
Megavitamin and orthomolecular therapy in psychiatry.
Topics: Aged; Alcoholism; Ascorbic Acid; Avitaminosis; Child; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Folic Acid; Humans; Mental Disorders; NAD; Nicotinic Acids; Psychiatry; Pyridoxine; Schizophrenia; Substance-Related Disorders; Vitamin B 12; Vitamins | 1974 |
Letter: NAD and chronic schizophrenia.
Topics: Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Humans; NAD; Niacinamide; Nicotinic Acids; Schizophrenia | 1974 |